Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Acadia, adjunctive, adjunctively, aforementioned, akathisia, Allergan, AMPA, antecedent, antipsychotic, apathy, Arbitrage, Ariosa, aripiprazole, Arizona, arm, arriving, article, aspartate, AstraZeneca, atypical, Bachelor, Baylor, bend, BioCardia, biofilm, bolstering, Cephalon, cessation, CGM, Chardan, ChemTrak, cholesterol, chorea, Circuit, clarifying, classification, CMC, cognition, Computershare, CTNI, departure, diagnostic, Diego, disorientation, distributionrestricted, disturbance, Division, double, Dow, dry, DuPont, dyskinesia, dysregulation, edema, eleven, emotion, Empery, enGene, England, EPS, exigent, Fava, Fischer, Gerard, Gin, Goldberg, Hal, Harvard, herewith, Hoe, home, Hospital, infused, injection, interior, IntraCellular, JAMA, Jerry, Jersey, John, Lane, Laughren, lessee, lifecycle, Livionex, Loyola, LP, macular, Mangement, Matthew, Maurizio, MBA, memory, MGH, Michael, Mintz, modest, Mountainview, mouth, necessity, NEJM, Neuroendocrinology, Neuropsychiatry, noncash, nonrecurring, Norac, notably, Nuvora, Oculex, Ono, Osteo, partly, Pharmatek, piece, Plaza, plc, PLTG, PPD, PPVA, PreferredCertificate, propelling, psychiatry, psychopharmacology, puruant, QC, Quest, rapastinel, renowned, River, Rockefeller, Rush, Ryan, Sabby, Saddle, Sanacora, Sanjay, Sanofi, se, Septermber, Sequenom, sexual, Shire, sit, sleep, Smith, smooth, solution, sore, SSRI, straight, syndrome, Syntex, Syva, tardive, Teva, therefrom, Thermo, topline, twenty, unblinded, unconsummated, uncontrolled, Underwriting, underwritten, Upper, USPTO, vi, VTGN, WallachBeth, withhold, WO, workload, wound, Yale
Removed:
absent, acceleration, albumin, anniversary, arrhythmia, assistance, astemizole, auditory, Australia, behave, biographical, BLA, bladder, boardroom, BPM, breakdown, BS, CA, cadaver, cancel, CDN, charge, cisapride, closed, commit, committed, computational, confirming, consenting, consisted, constituted, countervailing, default, define, deter, devoted, directorship, diversity, documented, dramatically, earliest, ease, effected, efficiency, endeavor, endocrine, endoderm, enrich, enzyme, epiblast, ES, experimentally, familiarity, fat, fate, flat, formalized, freedom, gland, greatly, gut, hereof, Hong, humanized, incumbent, inducing, influencing, inheritable, inside, insulin, integral, integrity, interdisciplinary, Japan, Kong, Korean, lawful, leasing, lidocaine, lifespan, Lonza, lung, mandatorily, marker, MDSCC, mesendoderm, mesoderm, modifying, month, mRNA, MSSM, neuroectoderm, nifedipine, nominee, opposite, organic, patenting, penalty, pink, plastic, pluripotency, pluripotential, powerful, precisely, predispose, prefer, premise, prominence, properly, propose, propranolol, protected, PTO, pure, quotation, ratifying, reelection, replace, reporter, reprogrammed, reprogramming, restructured, rifampicin, satisfied, secretion, sertindole, shareholder, signature, Singapore, solid, sorting, sotalol, speed, stead, step, stimulate, subjective, substitute, tendered, tenure, therewith, thing, thyroid, Trillium, true, UC, uncured, upcoming, urea, vacancy, validate, verapamil, view, waive, WHEREOF, woman
Filing tables
Filing exhibits
- 10-K Annual report
- 10.112 Indemnification Agreement Effective April 8, 2016 Between the Company and Jerry B. Gin
- 10.116 Second Amendment to Employment Agreement by and Between Vistagen Therapeutics, Inc. and Shawn K. Singh
- 10.117 Second Amendment to Employment Agreement by and Between Vistagen Therapeutics, Inc. and H. Ralph Snodgrass, PH.D.,
- 23.1 Consent of Independent Registered Public Accouting Firm
- 31.1 Certification of the Company's Chief Executive Officer Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 31.2 Certification of the Company's Chief Financial Officer Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 32.1 Certification of the Company's Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- Download Excel data file
- View Excel data file
VTGN similar filings
Filing view
External links